Recent development of microfluidics-based platforms for respiratory virus detection.

Area of Science:

• Biomedical Engineering
• Infectious Disease Diagnostics
• Nanotechnology

Background:

• The global SARS-CoV-2 pandemic highlighted limitations in current respiratory virus detection technologies.
• Traditional methods (cell culture, RT-PCR, immunoassays) are often slow, labor-intensive, and require specialized facilities.
• There is a critical need for rapid, portable, accurate, and sensitive diagnostic assays for respiratory pathogens.

Purpose of the Study:

• To review recent advancements in microfluidics for respiratory virus detection.
• To highlight the advantages of microfluidics over conventional diagnostic methods.
• To discuss the future potential of microfluidic technologies in respiratory virus diagnostics.

Main Methods:

• Review of current literature on microfluidics-based diagnostic techniques for respiratory viruses.
• Categorization of microfluidic devices into paper-based, continuous-flow, and droplet-based systems.
• Analysis of the performance and applications of various microfluidic platforms.

Main Results:

• Microfluidics enables simple, rapid, accurate, and cost-effective analysis of viruses, antigens, antibodies, and nucleic acids.
• Paper-based, continuous-flow, and droplet-based microfluidic devices show significant promise for point-of-care diagnostics.
• These technologies can overcome the limitations of conventional methods in terms of speed, portability, and resource requirements.

Conclusions:

• Microfluidics-based techniques represent a significant advancement in respiratory virus diagnostics.
• These technologies are well-suited to meet the demands of rapid detection during infectious disease outbreaks.
• Continued development of microfluidic platforms will enhance global preparedness for future respiratory pandemics.